Competition will likely be intense for these important tax credits and grants, which are available for qualified life-science investments as part of the Secretary of the Treasury's program to promote so-called 'therapeutic discovery projects,' explained Drzal, a Blacksburg, Virginia-based shareholder in the firm who serves as general counsel to a number of biotech and other emerging companies.